• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Edgewise Therapeutics, Inc. - Common Stock (NQ:EWTX)

    15.81 +0.75 (+4.98%)
    Streaming Delayed Price Updated: 3:04 PM EDT, Oct 20, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 614,643
    Open 15.33
    Bid (Size) 15.82 (1)
    Ask (Size) 15.87 (3)
    Prev. Close 15.06
    Today's Range 15.07 - 16.08
    52wk Range 10.60 - 38.12
    Shares Outstanding 105,341,296
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -41.5%
    -41.5%
    1 Month
    +10.9%
    +10.9%
    3 Month
    +18.1%
    +18.1%
    6 Month
    +18.9%
    +18.9%
    1 Year
    -54.6%
    -54.6%

    More News

    Read More
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    Edgewise Therapeutics Inc (NASDAQ:EWTX) Q2 2025 Earnings: EPS Beat Sparks 5% Pre-Market Rally
    Via Chartmill
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    Via ACCESS Newswire
    This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
    Via ACCESS Newswire
    No Accelerated FDA Approval For Edgewise's Rare Muscular Disease Drug; Shares Fall
    Via Benzinga
    Top movers in Friday's after hours session
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Edgewise Therapeutics Stock Popped This Week
    Via The Motley Fool
    Tesla, Nvidia, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
    Via Benzinga
    Top movers in Wednesday's session
    Via Chartmill

    Frequently Asked Questions

    Is Edgewise Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Edgewise Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Edgewise Therapeutics, Inc. - Common Stock trade on?
    Edgewise Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Edgewise Therapeutics, Inc. - Common Stock?
    The ticker symbol for Edgewise Therapeutics, Inc. - Common Stock is EWTX on the Nasdaq Stock Market
    What is the current price of Edgewise Therapeutics, Inc. - Common Stock?
    The current price of Edgewise Therapeutics, Inc. - Common Stock is 15.81
    When was Edgewise Therapeutics, Inc. - Common Stock last traded?
    The last trade of Edgewise Therapeutics, Inc. - Common Stock was at 10/20/25 03:04 PM ET
    What is the market capitalization of Edgewise Therapeutics, Inc. - Common Stock?
    The market capitalization of Edgewise Therapeutics, Inc. - Common Stock is 1.67B
    How many shares of Edgewise Therapeutics, Inc. - Common Stock are outstanding?
    Edgewise Therapeutics, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.